Newsletter Summer 2011

At the MERMAID Project we are pleased to be able to inform you of events and developments of the project since last summer- both in terms of research and fundraising.

As described in the Christmas letter the research in MERMAID I, ovarian cancer was, completed in December with a review by the independent monitoring group (IAC), who among other things wrote about the project and the research:

“The IAC can conclude, without hesitation, that this has been one of the most important and productive scientific initiatives within the field of gynecological cancer research. The MERMAID I has not only produced new knowledge for the benefit of women baring the risk of or with ovarian cancer, but also sets the scene for the future scientific activity within this area.”

The research in MERMAID II, cervical cancer, reached in the autumn remarkable results since it has managed to identify one of the HPV virus types as being by far more dangerous and more frequent than other HPV virus types. These results were published in the international scientific journal “Journal of the National Cancer Institute”. It is likely that the results can be used clinically in the near future, so that one can become better at identify – and assisting – the women who are at particular risk of getting cervical cancer.

MERMAID’s independent committee of experts, Monitoreringsgruppen, gave its first evaluation of MERMAID II in December 2010. The experts expressed great praise in respect of the research and highlighted the importance of the results. The next evaluation will be conducted at the end of this year.

During this spring of 2011 commitments/funds were received for the project so that MERMAID II, which has a budget of 26.3 million Danish kroner is now fully funded.

The researchers in the MERMAID project, has been included in an important international collaboration with international researchers. TheMERMAID project is now a part of a larger consortium, OCAC, which consists of 12 partners from such America, Australia, Germany and UK. Recently MERMAID also became a part of another large international consortium, COGS, who collaborate on research in breast, ovarian and prostate cancer. Here MERMAID is the driving force of the research in ovarian cancer.

On behalf of the researchers and the many volunteers in the MERMAID project we want to thank all the donors who have helped to make the important research possible – and we wish all a good and enjoyable summer!

Christian Munk, MD, ph.d., receives in June 2011 on behalf of the MERMAID Project a donation from Lotte Sehested Nerem and Birgit Sehested Hansen who represent “Poul og Erna Sehested Hansens Fond”.

Christian Munk, MD, ph.d., receives in June 2011 on behalf of the MERMAID Project a donation from Lotte Sehested Nerem and Birgit Sehested Hansen who represent “Poul og Erna Sehested Hansens Fond”.

Best regards
Birgitte Blix Treschow

Project Coordinator